A direct method and icer tables for the estimation of the cost-effectiveness of smoking cessation interventions in general populations: Application to a new cytisine trial and other examples

Nicotine and Tobacco Research

Volumn 14, Issue 4, 2012, Pages 463-471

  Stapleton, John A ^a   West, Robert ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE PATCH;

ARTICLE; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; GROUPS BY AGE; HEALTH CARE POLICY; HEALTH STATUS; HUMAN; INCREMENTAL COST EFFECTIVENESS RATIO; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RELAPSE; SMOKING CESSATION; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICAL PARAMETERS; TOBACCO DEPENDENCE;

ADULT; AGED; AGED, 80 AND OVER; ALKALOIDS; AZOCINES; COST-BENEFIT ANALYSIS; FEMALE; HEALTH PROMOTION; HUMANS; LIFE EXPECTANCY; LIFE TABLES; MALE; MIDDLE AGED; MODELS, STATISTICAL; NICOTINE; QUALITY-ADJUSTED LIFE YEARS; QUINOLIZINES; SMOKING; SMOKING CESSATION;

EID: 84859261209     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntr236     Document Type: Article

References (18)

1. Bauld, L., Boyd, K. A., Briggs, A. H., Chesterman, J., Ferguson, J., Judge, K., et al. (2011). One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services. Nicotine & Tobacco Research, 13, 135-145. doi:10.1093/ntr/ntq222
2. Cromwell, J., Bartocsch, W. J., Fiore, M. C., Hasselblad, V., & Baker, T. (1997). Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation Journal of the American Medical Association, 278, 1759-1766. doi:10.1001/jama.278.21.1759
3. Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004). Mortality in relation to smoking: 50 years' observations on male British doctors. British Medical Journal, 328, 1519-1530. doi:10.1136/bmj.38142.554479.AE
4. Drummond, M. F., Stoddart, G. L., & Torrance, G. W. (1987). Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press.
5. Etter, J. F., & Stapleton, J. A. (2006). Nicotine replacement therapy for long term smoking cessation: A meta analysis. Tobacco Control, 15, 280-285. doi:10.1136/tc.2005.015487
6. Fiscella, K., & Franks, P. (1996). Cost-effectiveness of the transdermal nicotine patch as an adjunct to physician's smoking cessation counselling. Journal of the American Medical Association, 275, 1247-1251. doi:10.1001/jama.275.16.1247
7. Furlong, C. (2005). Preoperative smoking cessation: A model to estimate potential short term health gain and reductions in length of stay. (A report by the London Health Observatory). London: London health Observatory.
8. Hughes, J. R., Peters, E. N., & Naud, S. (2008). Relapse to smoking after 1 year of abstinence: A meta-analysis. Addictive Behaviours, 33, 1516-1520. doi:10.1016/j.addbeh.2008.05.012
9. Javitz, H. S., Zbikowski, S. M., Deprey, M., McAfee, T. A., McClure, J. B., Richards, J., et al. (2010). Cost-effectiveness of varenicline and three different behavioral treatment formats for smoking cessation. Translational Behavioral Medicine. 1, 182-190.
10. National Institute for Health and Clinical Excellence. (2002). Technology appraisal guidance No. 39. Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation. London: National Institute for Health and Clinical Excellence.
11. Oster, G., Huse, D. M., Delea, T. E., & Colditz, G. A. (1986). Cost-effectiveness of nicotine gum as an adjunct to physicians' advice against cigarettes smoking. Journal of the American Medical Association, 256, 1315-1318. doi:10.1001/jama.256.10.1315
12. Reeves, S., & Bernstein, I. (2008). Effects of maternal tobacco-smoke exposure on fetal growth and neonatal size. Expert Review of Obstetrics and Gynecology, 3, 719-730.
13. Rehan, V. K., Asotra, K., & Torday, J. S. (2009). The effects of smoking on the development of the lung: Insights from a biological model for lung development, homeostasis, and repair. Lung, 187, 281-289. doi:10.1007/s00408-009-9158-2
14. Silagy, C., Lancaster, T., Stead, L., Mant, D., & Lancaster, T. (2008). Nicotine replacement therapy for smoking cessation. Cochrane Library3). Oxford: Update Software. CD000146.
15. Stapleton, J. A. (1998). Smoking prevalence, cessation and relapse. Statistical Methods in Medical Research, 7, 187-203. doi:10.1191/096228098671391775
16. Stapleton, J. A., Lowin, A., & Russell, M. A. H. (1999). Prescription of transdermal nicotine patches for smoking cessation in general practice: Evaluation of cost-effectiveness. The Lancet, 354, 210-215. doi:10.1016/S0140-6736(99)90001-6
17. U.S. Department of Health and Human Services. (1990). The health benefits of smoking cessation. U.S. Department of Health and Human Services. Public Health Service. Centers for Disease Control. Center for Chronic Disease Prevention and Health Promotion. Office on Smoking and Health. Atlanta, GA: DHHS Publication No. (CDC) 90-48-116.
18. West, R., Zatonski, W., Cedzynska, M., Lewandowska, D., Pazik, J., Aveyard, P., et al. (2011). Randomised placebo-controlled trial of cytisine for smoking cessation. New England Journal of Medicine. 365, 1193-1200.